Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from IDEXX Laboratories

Is IDEXX Laboratories Stock Underperforming the Nasdaq?

IDEXX Laboratories has trailed the Nasdaq Composite over the past year, and analysts are fairly bullish on its future growth potential.

Barchart

IDEXX Laboratories Touts AI Push, inVue Dx Momentum at Stifel Conference

IDEXX Laboratories (NASDAQ:IDXX) President and CEO Michael Erickson used a Stifel investor conference appearance to emphasize the company’s innovation pipeline, expanding commercial reach and growing use of software and artificial intelligence across veterinary diagnostics. Erickson, who recently b

MarketBeat

Is Wall Street Bullish or Bearish on IDEXX Laboratories Stock?

Although IDEXX Laboratories has lagged the broader market over the past year, Wall Street analysts remain fairly bullish about the company’s long-term growth prospects.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Is IDEXX Laboratories Stock Outperforming the S&P 500?

Despite outperforming the broader S&P 500 Index over the past year, analysts maintain a cautiously optimistic outlook on IDEXX Laboratories’ future prospects.

Barchart

Are Wall Street Analysts Bullish on IDEXX Laboratories Stock?

IDEXX Laboratories has outperformed the broader market over the past year, and analysts remain moderately bullish about the stock’s prospects.

Barchart

What to Expect From IDEXX Laboratories’ Next Quarterly Earnings Report?

IDEXX Laboratories is expected to release its fiscal fourth-quarter earnings soon, and analysts project a double-digit earnings increase.

Barchart

Idexx Laboratories Extends Rally Following Upbeat Q3 Earnings, Outlook

IDEXX Laboratories Inc.‘s (NASDAQ:IDXX) stock is trading higher on Monday after it reported better-than-expected third-quarter financial results and raised its 2025 forecast.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Idexx Laboratories Stock: Is Wall Street Bullish or Bearish?

IDEXX Laboratories' stock has significantly outperformed the broader market over the past year, but analysts are cautiously bullish about its growth potential.

Barchart

Why a Company You’ve Never Heard of Is One of the Best Nasdaq-100 Stocks of the Year

Going under the radar, shares of this vet tech company have been winners this year.

Barchart

Tesla, Delta Air, IDEXX Laboratories And More On CNBC's 'Final Trades'

In a volatile market landscape marked by rapid shifts in investor sentiment, financial experts are spotlighting key stocks and sectors poised for growth. On CNBC's “Halftime Report Final Trades,” Bryn Talkington, Managing Partner of Requisite Capital Management, recommended sticking with Tesla, Inc. (NASDAQ:TSLA).

Benzinga

Wayfair, CommScope Holding, Steelcase, IDEXX Laboratories And Other Big Stocks Moving Higher On Monday

U.S. stocks were higher, with the Dow Jones index gaining around 400 points on Monday.

Benzinga

IDEXX Surpasses Earnings Expectations, Justifying Premium Valuation

Pet healthcare is witnessing a surge in demand as more households prioritize their pets’ well-being, driving companies in this sector to outperform expectations. This trend is reflected in IDEXX Laboratories Inc.‘s (NASDAQ:IDXX) recent financial results, showcasing significant growth and revised earnings guidance.

Benzinga

Is IDEXX Laboratories Stock Outperforming the Dow?

IDEXX Laboratories has outpaced the Dow Jones Industrial Average this year, and analysts are reasonably upbeat about its future growth potential.

Barchart

IDEXX Laboratories Stock: Analyst Estimates & Ratings

IDEXX Laboratories has significantly outperformed the broader market in recent months, and analysts remain cautiously optimistic about the stock’s prospects.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Is IDEXX Laboratories Stock Underperforming the Nasdaq?

Despite IDEXX Laboratories’ underperformance relative to the broader Nasdaq Composite over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Barchart

Do Wall Street Analysts Like IDEXX Laboratories Stock?

IDEXX Laboratories has significantly outperformed the broader market in 2025 and analysts remain bullish on the stock’s prospects.

Barchart

IDEXX Laboratories' Quarterly Earnings Preview: What You Need to Know

IDEXX Laboratories plans to report its fiscal fourth-quarter earnings next month, and analysts expect its profit to rise in the single digits.

Barchart

Is IDEXX Laboratories Stock Underperforming the S&P 500?

IDEXX Laboratories has continued to underperform the S&P 500 over the past year, yet analysts remain moderately bullish on the stock’s prospects.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

A Glimpse Into The Expert Outlook On IDEXX Laboratories Through 5 Analysts

5 analysts have shared their evaluations of IDEXX Laboratories (NASDAQ:IDXX) during the recent three months, expressing a mix of bullish and bearish perspectives.

Barchart

IDEXX Laboratories' Q3 2024 Earnings: What to Expect

IDEXX Laboratories is scheduled to release its fiscal third-quarter earnings this month, and analysts project a single-digit profit growth.

Barchart

How Is IDEXX Laboratories' Stock Performance Compared to Other Healthcare Stocks?

IDEXX Laboratories underperformed the broader healthcare sector, but Wall Street analysts remain moderately optimistic about the stock’s prospects.

Barchart

Are Wall Street Analysts Predicting IDEXX Laboratories Stock Will Climb or Sink?

IDEXX Laboratories has underperformed the broader market over the past year, yet analysts remain moderately bullish on the stock’s prospects.

StockNews.com

3 High-Profitability Healthcare Stocks to Buy for Consistent Returns

The healthcare industry's growth is driven by expanding healthcare needs, fast-rising demand for care services, and the increasing demand for smart medical devices. Given this backdrop, investors could consider buying fundamentally strong healthcare stocks such as IDEXX Laboratories (IDXX), Veeva Systems (VEEV), and Chemed Corporation (CHE) given their solid profitability…

Barchart

IDEXX Laboratories Stock: Is IDXX Underperforming the Healthcare Sector?

IDXX Laboratories has recently underperformed the Healthcare sector, but Wall Street analysts are moderately optimistic about the stock’s prospects.

StockNews.com

T2 Biosystems (TTOO) vs. IDEXX Laboratories (IDXX): Which Medical Stock Is Poised for More October Gains?

With an aging population worldwide, the rising prevalence of chronic diseases, and numerous technological advancements, the medical device sector stands primed for considerable growth and expansion. The industry tailwinds should benefit medical device stocks T2 Biosystems (TTOO) and IDEXX Laboratories (IDXX). However, which stock is poised for better gains this…

1 2

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Requisite Capital Management

21 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Cancer

24,516 stories

Artificial Intelligence

7,182 stories

Dow Jones Industrial Average

678 stories

Places

United States

404,112 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.